HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC - RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT ownership

RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT's ticker is and the CUSIP is H6759S100. A total of 3 filers reported holding RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC ownership history of RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT
ValueSharesWeighting
Q1 2023$6
-40.0%
300,0000.0%0.00%
-50.0%
Q4 2022$10
-99.9%
300,0000.0%0.00%0.0%
Q3 2022$8,000
-20.0%
300,0000.0%0.00%0.0%
Q2 2022$10,000
-50.0%
300,0000.0%0.00%
-66.7%
Q1 2022$20,0000.0%300,0000.0%0.01%0.0%
Q4 2021$20,000
-53.5%
300,0000.0%0.01%
-57.1%
Q3 2021$43,000
+13.2%
300,000
+71.4%
0.01%
+16.7%
Q2 2021$38,000
-29.6%
175,0000.0%0.01%0.0%
Q1 2021$54,000
+74.2%
175,000
+75.0%
0.01%
+50.0%
Q4 2020$31,000100,0000.01%
Other shareholders
RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT shareholders Q2 2022
NameSharesValueWeighting ↓
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 300,000$43,0000.01%
Stonebridge Financial Planning Group, LLC 45,780$4,0000.00%
HighPoint Advisor Group LLC 142,000$21,0000.00%
Ancora Advisors LLC 150,000$22,0000.00%
View complete list of RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT shareholders